Showing results (721-730 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|May 1, 2024
NIR-II light in clinical oncology: opportunities and challengesZeyu Zhang, Yang Du, Xiaojing Shi, et al.Nature Reviews. Clinical Oncology|October 12, 2023
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is neededAnushka Walia, Jordan Tuia, Vinay PrasadNature Reviews. Clinical Oncology|September 13, 2024
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistanceAdrienne G Waks, Olga Martínez-Sáez, Paolo Tarantino, et al.Nature Reviews. Clinical Oncology|February 24, 2026
Translating ferroptosis into oncology: challenges, opportunities and future directionsRui Kang, Jiao Liu, Jiayi Wang, et al.Nature Reviews. Clinical Oncology|May 15, 2026
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizonsHongcheng Zhu, Florian Lordick, Yelena Y Janjigian, et al.Nature Reviews. Clinical Oncology|March 10, 2026
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknownEdoardo Mannucci, Ilaria DicembriniNature Reviews. Clinical Oncology|February 18, 2026
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalizationDouglas B Johnson, Amin H Nassar, Ayesha Aijaz, et al.Nature Reviews. Clinical Oncology|July 21, 2023
The global burden of lung cancer: current status and future trendsAmanda Leiter, Rajwanth R Veluswamy, Juan P WisniveskyNature Reviews. Clinical Oncology|April 28, 2026
Emerging trends in the global burden of colorectal cancerDavid J Lee, Aparna Parikh, Bhawna Sirohi, et al.Nature Reviews. Clinical Oncology|April 28, 2026
The clinical landscape of HIF2α inhibitors in oncologyEddy Saad, Marc Machaalani, David F McDermott, et al.Pageof 97